Delivery Order SPE2DB20D1100-SPE2DB25FA6K9

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,154.96, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corporation. The contract is for the delivery of 4566358010 - VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 7, 2024. Amerisourcebergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,494.63, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a specialty medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 11, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $19,952.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,731.86 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a medication. The contract has an ultimate completion date of February 2, 2024. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,048.02 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,636.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VRAYLAR 1.5 MG CAPSULE 30S. This contract, with a completion date of March 6, 2024, is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs...
This federal contract award, valued at $8,670.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and firm fixed-price instrument for the supply of VRAYLAR 1.5 MG capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,187.40 firm fixed price delivery order is for VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $5,894.56, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The delivery order contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 21, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
The federal contract award summarizes a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $6,369.80 firm-fixed-price contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA6K9
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $1,978.52 with Amerisourcebergen Drug Corp as the prime contractor. The award is for the supply of VRAYLAR 1.5 MG capsules in quantities of 30, with a completion date of February 18, 2025. The contract is a firm fixed-price arrangement without any set-aside designation.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 11:42 AM